In Q3 2025, RF MEDICAL strengthened its global presence through active collaboration with partners and medical experts worldwide. Distributors across the U.S., Indonesia, Latin America, and China led key congresses and training programs, expanding awareness of RF and MW ablation treatments.
Under the leadership of the newly appointed CEO, Robert Yoo, the
Mr. Robert Yoo (Kyung Hoon Yoo) has o cially assumed the position of Chief Executive O cer at RF Medical Co. Ltd., e ective July 25, 2025. Mr. Yoo previously served as Chief Operating O cer (COO) and has played a pivotal role in strengthening the company’s global operations and strategic growth. This leadership transition follows the retirement of the company’s founder and long-serving president, Mr. Mike Jun (Myong Ki Jun), who led RF MEDICAL through more than two decades of innovation and growth since its establishment in 2003. The succession aligns with the company’s long-term vision for sustainable expansion and organizational excellence. With this transition, RF MEDICAL reiterates its commitment to advancing minimally invasive ablation technology and strengthening its global partnerships under the new leadership of Mr. Yoo.
KAR 2025 August 31 l Seoul, Korea
Korean Association of Radiologists 2025
RF MEDICAL participated in the Korean Association of Radiologists (KAR) 2025 Annual Congress on August 31, 2025, engaging with interventional radiology experts across Korea. At the booth, we showcased our key systems — MYGEN™ multi-purpose RFA system, THYBLATE™ thyroid RFA system, Mi-BLATOR™ MWA system. Visitors showed strong interest in the THYBLATE™ adjustable active-tip electrodes and MWA multi-step protocol, recognizing RF MEDICAL’s commitment to precision and innovation.
KCITA 2025 September 6 l Seoul, Korea
Korean Congress of Image-guided Tumor Ablation 2025
RF MEDICAL participated in the Korean Society of Interventional Tumor Ablation (ITA) 2025 on September 6, engaging with leading specialists in tumor ablation.
During the scientific session, our Mi-BLATOR™ Microwave Ablation System was featured, highlighting its MULTI-STEP Mode for controlled energy delivery and a range of antenna options. These advanced features captured strong interest from attending physicians. In the afternoon, we conducted a hands-on demonstration, allowing participants to observe live procedures and experience Mi-BLATOR™’s precision, reliable performance, and broad ablation capability. The session generated active discussions and positive feedback from physicians seeking reliable ablation solutions.
KCOG 2025 September 14 l Seoul, Korea
The Korean College of Obstetricians and Gynecologists 2025
The Autumn Congress 2025, held on September 14 in Seoul, is one of Korea’s leading OB-GYN congress, bringing together thousands of physicians and over 100 companies from medical, pharmaceutical, and women’s health fields.
At our booth, we introduced RF MEDICAL’s RF Ablation System, which has been widely applied in gynecological procedures such as endometrial ablation and uterine fibroid treatment. Many physicians visited to learn about the system’s precision control and safety features, showing particular interest in its potential to improve patient recovery and reduce invasiveness.
The congress served as an excellent opportunity to strengthen RF MEDICAL’s presence in women’s healthcare.
KAES 2025 September 21 l Seoul, Korea
Korean Association of Endocrine Surgeons 2025
RF MEDICAL participated in the Korean Association of Endocrine Surgeons (KAES) 2025 on September 21, focusing on a hands-on session featuring the THYBLATE™ RFA System.
Led by Dr. Byeong-seop Kim and Dr. Rami Kim, a hands-on session engagement was high, and discussions extended beyond the scheduled time. Many attendees showed strong interest in THYBLATE™, with one surgeon arranging a follow-up visit to RF MEDICAL HQ for deeper collaboration.
In the scientific sessions, the newly released ATA 2025 Guidelines reflect a global shift in the management of low-risk papillary thyroid microcarcinoma (cT1aN0M0 PTC). They emphasize moving away from surgery as the default approach, toward more individualized options, including Active Surveillance and Radiofrequency Ablation (RFA) for carefully selected patients.
KCR 2025 September 24-27 l Seoul, Korea
Korean Congress of Radiology 2025
The 81 st Korean Congress of Radiology (KCR 2025) was successfully held in Seoul under the slogan “Unwavering Endeavors,” gathering over 3,600 participants from 38 countries. As one of Asia’s leading radiology meetings, the congress featured high-quality lectures and international collaboration. We also took part with our booth, welcoming international visitors, introducing our latest products, and celebrating the special 80 th anniversary session of the Korean Society of Radiology.
WCTC 2025 July 9-12 l Boston, USA
The World Congress on Thyroid Cancer
The World Congress on Thyroid Cancer (WCTC) 2025 in Boston gathered global experts to share insights into the latest thyroid ablation techniques.
RF MEDICAL, together with our U.S. partner RGS Healthcare, participated with both booth exhibition and active involvement in the Ablation Course RFA, where our THYBLATE™ system was featured in the didactic lecture and hands-on sessions led by renowned specialists.
Their strong local support played a key role in facilitating the event and engaging with attending physicians throughout the congress.
ATA 2025 September 10-14 l Arizona, USA
Annual Meeting of the American Thyroid Association 2025
At the ATA 2025 Annual Meeting in Arizona, RF MEDICAL reinforced its leadership in thyroid ablation therapy through extensive on-site activities. During the Introduction to Interventional Endocrinology Course, participants experienced the THYBLATE™ system in ultrasound-guided RFA hands-on training, led by Dr. Richard Harding and Dr. Julia E. Noel, attracting about 20 physicians and generating new leads.
At the exhibition booth, operated with strong support from RGS Healthcare, numerous physicians from across the U.S. and Latin America explored the system’s precision and safety features, including many new clinicians beginning thyroid ablation.
The ATA Dinner Session, “The Next Frontiers in Thyroid Ablation,” gathered around 25 specialists from the U.S., Brazil, and Colombia. Presentations by Dr. Tufano, Dr. Rangel, Prof. Wei-Che Lin, and Dr. Volpi sparked active discussions on clinical advances, particularly in parathyroid and PTMC.
These events collectively highlighted RF MEDICAL’s continued commitment to advancing minimally invasive endocrine care through close collaboration with RGS Healthcare.
CIRSE 2025 September 13-17 l Barcelona, Spain
Cardiovascular and Interventional Radiological Society of Europe 2025
RF MEDICAL participated in CIRSE 2025, held in Barcelona, Spain, the leading congress for interventional radiology in Europe. Throughout the event, we showcased our latest technologies at booth and conducted Hands-on Device Training sessions for both varicose vein treatment (VeinCLEAR™) and tumor ablation (MYGEN™), o ering participants valuable opportunities for practical experience with our minimally invasive systems.
In addition to product demonstrations, we met with existing distributors from across the Globe and explored new partnership opportunities in Latin America, the Middle East, and Asia.
CIRSE o ered valuable insights into market trends and physicians’ procedural preferences across a wide range of interventional radiology applications, highlighting the vast potential for our products’ growth and adoption.
RF MEDICAL China, together with its regional distributors, participated in key medical conferences across major cities, showcasing the M-3004C Radiofrequency Ablation System and its role in ultrasound-guided ablation.
ECAMBSTTPCACSDSP 2025
August 22 l Dezhou, China
Establishment Conference and Academic Meeting of the Bone and Soft Tissue Tumor Professional Committee of the Anti-Cancer Society of Dezhou City, Shandong Province
At the event, experts in thyroid and tumor ablation explored the latest developments in minimally invasive therapy. Many attendees visited our booth to learn about the system’s precision control, safety features, and clinical versatility, expressing strong interest in its application to thyroid ablation.
ACUPBGMA 2025
August 23-24 l Guangzhou, China
Annual Conference of the Ultrasound Physicians' Branch of Guangdong Medical Association
Our team in China actively exchanged insights with ultrasound and interventional specialists, introducing RF MEDICAL’s M-3004C, core ablation technologies, and clinical support services. Their e orts aimed to enhance awareness of high-quality RF ablation solutions and contribute to improving patient outcomes in support of the “Healthy Guangdong” initiative.
ACUMBCGMA 2025
September 20-21 l Wuhan, China
2025 The 5th Academic Conference of the Ultrasound Medicine Branch of the Chinese Geriatrics Medical Association
As part of the event, RF MEDICAL showcased the M-3004C Radiofrequency Ablation System through live demonstrations, highlighting its precision and e ciency in minimally invasive ablation—an area that drew strong interest from attending specialists.
ACUMBCHIEPA 2025
September 27 l Changsha, China
2025 2025 Annual Conference of the Ultrasound Medicine Branch of the China Healthcare International Exchange Promotion Association
As part of the conference program, the team showcased the M-3004C Radiofrequency Ablation System through a combination of physical display and model-based demonstrations, emphasizing its precision, e ciency, and clinical value in ultrasound-guided ablation.
August 1-2 l Santiago, Chile
Congreso Latinoamericano de Terapias Ablativas Térmicas en Tiroides
The II Latin American Congress on Thermal Ablation Therapies for Thyroid (TAT 2025) was held in Santiago, Chile, bringing together experts from across Latin America for two days of innovation and live learning.
RF MEDICAL, in partnership with Thiemed, supported two hands-on workshop stations featuring the THYBLATE™ system, providing participants with practical experience in thyroid RFA techniques.
The sessions, led by distinguished physicians from Brazil, Chile, Argentina, Colombia and USA, highlighted the growing adoption of minimally invasive ablation procedures in the region.
Through our active participation, RF MEDICAL continues to strengthen its presence and partnerships throughout Latin America.
September 3-5 l Balneário Camboriú, Brazil
Congresso Brasileiro de Cirurgia de Cabeça e Pescoço
RF MEDICAL’s Brazilian distributor, Surgicalline, participated in the Brazilian Congress of Head and Neck Surgery (CBCCP 2025) held from September 3–5.
At the booth, the team introduced RF MEDICAL’s THYBLATE-V2™, latest thyroid ablation electrodes, engaging with ENT and head & neck specialists from across Brazil. Live demonstrations and educational discussions highlighted the precision and safety of our minimally invasive technologies, drawing strong interest from attending physicians.
Surgicalline’s active participation helped amplify RF MEDICAL’s presence and brand visibility throughout the Latin American market.
September 23-26 l Tehran, Iran
International Congress on Cardiovascular Updates
At the ICCU 2025 in Iran, RF MEDICAL’s distributor eSperlous showcased the VeinCLEAR™ system through booth activities and a live demonstration.
The session featured VeinCLEAR™’s precise energy control, uniform vein closure, and fast recovery performance, drawing strong attention from attending physicians.
Medical professionals observed real-time procedures and experienced the safety and e ciency of RF MEDICAL’s radiofrequency technology.
PT. Natural Hilife, the first overseas partner to launch Mi-BLATOR™ and achieve initial sales, deserves our congratulations on this milestone. Covering all possible applications of our products and quickly adopting new innovations, their relentless e orts, successful market entry, and strong collaboration continue to drive growth. We sincerely thank them for their dedication and partnership in advancing minimally invasive ablation therapies across Indonesia
July 16-19 l Malang, Indonesia
2025 National Working Conference organized by the Indonesian Association for the Study of the Liver (PPHI), Indonesian Society of Gastroenterology (PGI), and Indonesian Society for Digestive Endoscopy (PEGI)
At the congress, PT. Natural Hilife actively supported the national hepatologist community while promoting the upcoming masterclass in September. Through its booth activities, the recently launched Mi-BLATOR™ in Indonesia was actively showcased, engaging physicians and highlighting its innovative features and clinical benefits.
August 20-23 l Bandung, Indonesia
The 6th Biennial Meeting of Indonesian Association for In Vitro Fertilization
Dr. Doddy Budi Laksana Sutanto delivered a lecture on “The Role of Endoscopic Ultrasound-Guided Radiofrequency Ablation in Uterine Fibroid and Adenomyosis,” highlighting the clinical value of RF ablation In line with his presentation, the MYOBLATE™ RFA system was prominently showcased at the booth, highlighting its advanced RF solutions for minimally invasive gynecological treatments. Attendees showed strong interest in its uterus-preserving applications, not only for fibroids but also for adenomyosis.
September 16-20 l Bandung, Indonesia
7th National Congress of the Indonesian Association of Surgeons & 22nd Sustainable Surgical Professional Development
At the booth, HEMO-BLATE™, the internally cooled RF system for hemorrhoid treatment, was introduced to participating surgeons, highlighting its minimally invasive advantages. On September 19, Dr. Oggy presented a lecture titled “Internally Cooled RF for Hemorrhoids: A New Paradigm in Minimally Invasive Care.” sharing his clinical experience and excellent outcomes with the HEMO-BLATE™ system.
with Dr. Saúl Siso & Dr. Pilar Schneeberger
THYBLATE™ Thyroid RFA Workshop with Thiemed
July 31 l Santiago, Chile
Together with Thiemed, RF MEDICAL held a Thyroid RFA Workshop on July 31, at Clinika Santa Maria, one of Santiago’s leading hospitals. Led by Dr. Saúl Siso and Dr. Pilar Schneeberger, the program gathered about 10 head and neck specialists from the hospital and nearby institutions.
After lectures and hands-on sessions across two stations, the team performed a live case on a benign thyroid nodule, successfully completed in about 20 minutes. The workshop concluded with strong interest from local medical leaders, marking an important step toward broader clinical adoption of thyroid RFA in Chile.
with Dr. P. Bat-Ireedui
August 5-20 l Colombia & Ecuador MWA & RFA Series with Medinistros and Invimedic
RF MEDICAL successfully conducted a series of Microwave and Radiofrequency Ablation (MWA & RFA) masterclasses in Colombia and Ecuador, following Chile led by our distinguished KOL, Dr. P. Bat-Ireedui from Mongolia.
The sessions covered a wide range of applications, including HCC, thyroid, GYN treatments, allowing participating physicians to gain both theoretical knowledge and hands-on experience with MYGEN™, MYOBLATE™, and THYBLATE™ systems.
The masterclasses provided an excellent platform for local specialists to enhance their procedural confidence through real-time ultrasound-guided ablation training and live demonstrations.
Dr. Ireedui’s expertise and practical guidance were highly praised by attendees, strengthening RF MEDICAL’s commitment to expanding high-quality training and clinical excellence across Latin America.
with Prof. Benoît Rabischong, Prof. Revaz Botchorishvili, Dr. Martina Billeci, & Dr. Francesco Cannone
MYOBLATE™ Masterclass by LiNA Medical
July 7-11 l Clermont-Ferrand, France
LiNA Medical supported the International Masterclass in Minimally Invasive Surgery at CICE – International Center for Endoscopic Surgery in Clermont-Ferrand, bringing together 17 delegates from the UK, Austria, and Slovakia.
Participants enhanced their laparoscopic skills through interactive lectures, live surgeries, and hands-on simulations. A focused MYOBLATE™ workshop showcased the benefits of RF ablation for uterine fibroids and its growing role in minimally invasive gynecology.
with Dr. Doddy Sutanto, M.Kes
MYOBLATE™ Hands on Training
July 25 l Magelan, Indonesia
In Indonesia, Dr. Doddy, a leading gynecologist, conducted a MYOBLATE™ Masterclass focusing on radiofrequency ablation for uterine fibroids and adenomyosis.
The program o ered participants the opportunity to gain practical experience in ultrasound-guided ablation techniques. The course emphasized MYOBLATE™’s precision, ease of operation, and e ectiveness in treating benign uterine conditions, reinforcing its value as a reliable solution in gynecology.
with Prof. Wei-Che Lin
THYBLATE™ Masterclass in Indonesia
August 16 l Indonesia, Online
RF MEDICAL held an exclusive webinar for physicians in Saudi Arabia, led by Dr. Bramastha Aires Rosadi (Dr. Oggy) from Indonesia.
The session introduced the HEMO-BLATE™ Cooled RF system for hemorrhoid treatment, emphasizing its clinical safety, precision, and patient comfort. Drawing from nearly 100 successful cases, Dr. Oggy shared valuable insights and case-based experiences that strongly resonated with participating physicians.
The webinar marked a meaningful starting point for Saudi Arabian physicians entering hemorrhoid RFA, highlighting new possibilities for minimally invasive care.
August 29-30 l Indonesia, Yogyakarta
RF MEDICAL, in collaboration with PT. Natural Hilife, supported Thyroid RF Ablation Masterclass held at Soerojo Hospital in Magelang, Indonesia, on August 29.
The program featured international KOL Prof. Wei-Che Lin from Kaohsiung Chang Gung Memorial Hospital, who led lectures and live demonstrations on RFA using the THYBLATE™ electrode and MYGEN™ generator, focusing on the treatment of benign and malignant thyroid nodules.
The sessions, which included live surgery, symposium discussions, and interactive Q&A, provided valuable training for regional
The program attracted around 100 physicians, marking a highly successful event that reinforced growing clinical interest in
with Prof. Shuichiro Shiina
September 13-14 l Indonesia, Jakarta
RF MEDICAL ,in collaboration with PT. Natural Hilife, hosted a Microwave Ablation (MWA) Masterclass led by world-renowned expert Prof. Shuichiro Shiina. The two-day program gathered over 50 physicians, including participants from public hospitals, reflecting Indonesia’s growing interest in liver ablation.
Using the Mi-BLATOR™ system and fusion ultrasound guidance, Prof. Shiina performed four live procedures and supervised hands-on training sessions on bovine liver models.
The course provided practical insights into puncture technique, power control, and ablation precision—enhancing physicians’ skills and strengthening Indonesia’s capacity for minimally invasive liver treatment.
with Dr. Lee Sung Hoon
September 2 l Shanghai, China
On September 2, 2025, an academic exchange on thermal ablation for uterine fibroids and adenomyosis was held at the Ultrasound Department of Shanghai Tenth Hospital, organized by RF MEDICAL China.
The meeting gathered experts from China and South Korea, including Dr. Lee Sung Hoon of Namu-jungwon Women’s Hospital and leading professors from Shandong and Tongji University hospitals. Participants observed live ablation procedures and shared clinical insights on optimizing treatment outcomes. Dr. Lee presented innovative Korean approaches for complex cases, emphasizing the value of thermal ablation in gynecologic care.
This exchange opened new opportunities for collaborative learning and set the stage for future developments in gynecologic ablation led by RF MEDICAL.
August 21 l Seoul, Korea
Dr. Bramastha Aires Rosadi (Dr. Oggy) from Indonesia visited RF MEDICAL headquarters in Korea During his visit, Dr. Oggy and Professor Kwang-Dae Hong from Korea University Ansan Hospital had a meaningful time sharing their knowledge and clinical experiences in Proctology RFA. And also toured our facilities, where he participated in demonstrations of our products currently in development.
The visit reinforced collaboration on expanding applications in proctology, not only in Indonesia but also with a view toward global initiatives, paving the way for future clinical training and partnerships.
As an international expert trainer for hemorrhoid ablation, Dr. Oggy was also presented with an Expert Trainer Certificate in recognition of his contribution to advancing global physician education.
RF MEDICAL welcomed Dr. Gustavo de Los Santos from Brazil
August 25 l Seoul, Korea
RF MEDICAL had the honor of welcoming Dr. Gustavo de Los Santos, a leading Brazilian KOL in interventional medicine, to our headquarters in Korea.
During his visit, Dr. Santos was introduced to RF MEDICAL’s history, global activities, and product portfolio, including the company’s latest ablation technologies. He also toured the manufacturing and R&D facilities, gaining firsthand insight into the company’s commitment to precision, safety, and innovation.
This visit served as an opportunity to strengthen collaboration and exchange clinical perspectives between RF MEDICAL and the Brazilian medical community, laying the foundation for future partnerships in advancing minimally invasive treatment solutions.
With the continued and successful use of our technologies in both existing and new clinical settings, we remain committed to advancing patient care and expanding access to innovative treatment options worldwide.
Argentina
July 25
On July 25 (Friday), Dr. Pedro Brégoli, Head and Neck Surgeon at Hospital de Clínicas, successfully performed the first THYBLATE™ thyroid ablation procedure in Argentina.
The case marked a major milestone for RF MEDICAL in Latin America, showcasing the growing adoption of minimally invasive thyroid treatments in the region.
Following the successful procedure, Dr. Brégoli met with RF MEDICAL’s Global Sales Director, Andy, during the Masterclass held in Chile this August, further strengthening the partnership and commitment to expanding THYBLATE™ education across South America.
France
July 29
Dr. Hervé Monpeyssen, a distinguished endocrinologist based in Paris, has been a long-term user of RF MEDICAL’s thyroid ablation system and reports high satisfaction with its performance. He plans to continue utilizing our product at his new private clinic in Paris, which is expected to open later this year.
Dr. Monpeyssen first began using RF MEDICAL’s system during his tenure at a public hospital and has since continued due to the reliable service and strong technical support provided by VO Medica, our distributor in France.
As THYBLATE™ thyroid RF ablation reimbursement progresses in the country, his ongoing use of our technology further reinforces RF MEDICAL’s growing presence in the French endocrine community.
Germany
July 29
As part of our e orts to re-engage the German market, we conducted two thyroid procedures in collaboration with Dr. Eisele, both of which were successfully completed. The visit proved to be a valuable opportunity to discuss future educational activities and potential collaborative initiatives.
We are expanding our reach with new multilingual resources and region-specific materials, ensuring better accessibility and targeted communication as we continue to grow in key markets.
* The materials shown on this page are available upon request.
As
As we move into the forth quarter, we are gearing up for new opportunities and continued growth. Stay tuned for upcoming events, product developments, and market expansions in the months ahead!